Since 1924, we have been educating and supporting scientists throughout Pennsylvania by striving to promote science, technology, education and the diverse interests of our members. We strive to be a vital and valuable resource for Pennsylvania science professionals, faculty, and students.

The Pennsylvania Academy of Science seeks to:

  • Advance the pursuit and application of science within the Commonwealth, both in academic and industrial settings.
  • Enhance the professional development of its members.
  • Create forums for professional dialogue among junior and senior scientists at all academic levels.
  • Promote scientific research, presentation and discussion among its members and the public at large.
  • Support educational initiatives devoted to the development of scientific skills and knowledge.

News and Updates

The 100th Annual Meeting of the Pennsylvania Academy of Science

will be held at Harrisburg University of Science and Technology in the capital of PA!

April 11–13, 2025

To learn more about Harrisburg University…Harrisburg University of Science and Technology | Transform Your Future

Contact for questions: Cathy Santai CSantai@harrisburgu.edu

2024 Keynote Speaker Dr. David B. Olsen

David B. Olsen, Ph.D.

Scientific Associate VP

Merck Research Laboratories

Neglected Tropical Diseases Discovery Lead

Title

Twists and turns in drug discovery: An antimalarial drug discovery case study that deciphers unique biology and identifies a potent development drug candidate.

Abstract

Malaria is a devastating disease that directly effects over half a million people each year with the most devastating and debilitating effects on young children. Antimalarial drug discovery by and large is focused on the identification of novel drugs to treat and prevent the disease due to the emergence and spread of Plasmodium strains resistant to existing medicines. In particular, artemisinin resistance which has now spread from SE Asia and is firmly established in Africa (as reported at ASTMH in Seattle Oct 2022).

Merck, a large pharmaceutical company, paired up with an academic collaborator, Professor Alan Cowman and his colleagues to do some malaria parasite drug hunting. The resulting collaboration identified robust targeted aspartyl protease screening hits that required some creative biochemical target identification to nail down the exact mechanism of the molecules. With some expert medicinal chemistry and detailed biological deciphering the team ended up with dual targeting molecules that are functionally active during the liver, blood and mosquito stage of the parasite’s replication cycle.

PA Governor’s Science & Technology Fellowship

Become a Member

Login